scholarly journals Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology

2020 ◽  
Vol 9 (2) ◽  
pp. 183-197 ◽  
Author(s):  
Uwe Zeymer ◽  
Hector Bueno ◽  
Christopher B Granger ◽  
Judith Hochman ◽  
Kurt Huber ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Clinical Trials ◽  
Cardiogenic Shock ◽  
Position Statement ◽  
Diagnosis And Treatment ◽  
Randomised Clinical Trials ◽  
Current Evidence ◽  
Care Association ◽  
Cardiovascular Care

Most of the guideline-recommended treatment strategies for patients with acute coronary syndromes have been tested in large randomised clinical trials. Still, a major challenge is represented by patients with acute myocardial infarction admitted with impending or established cardiogenic shock. Despite early revascularization the mortality of cardiogenic shock remains high and roughly half of patients do not survive until hospital discharge or 30-day follow-up. However, there is only limited evidence-based scientific knowledge in the cardiogenic shock setting. Therefore, recommendations and actual treatments are often based on retrospective or prospective registry data and extrapolations from randomised clinical trials in acute myocardial infarction patients without cardiogenic shock. This position statement will summarise the current consensus of the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock based on current evidence and will provide advice for clinical practice.

scholarly journals Modern approaches to the diagnosis and treatment of cardiogenic shock complicating acute myocardial infarction

2020 ◽  
Vol 19 (5) ◽  
pp. 2661
Author(s):  
A. Yu. Serdechnaya ◽  
I. A. Sukmanova
Keyword(s):  
Myocardial Infarction ◽  
Risk Assessment ◽  
Acute Myocardial Infarction ◽  
Cardiogenic Shock ◽  
Contractile Function ◽  
Diagnosis And Treatment ◽  
Assessment Score ◽  
Tissue Hypoperfusion ◽  
Modern Classification

Cardiogenic shock (CS) is the most severe complication of myocardial infarction, manifested by an acute tissue hypoperfusion as a result of impaired contractile function of the heart. CS occupies a leading place in the patterns of mortality in patients with myocardial infarction, despite all the advances in medicine. This review presents a modern classification of CS and a risk assessment score, considers the main aspects of epidemiology and pathophysiology of CS, discusses issues of its diagnosis and treatment.

scholarly journals Quality indicators for acute myocardial infarction: A position paper of the Acute Cardiovascular Care Association

2016 ◽  
Vol 6 (1) ◽  
pp. 34-59 ◽  
Author(s):  
Francois Schiele ◽  
Chris P Gale ◽  
Eric Bonnefoy ◽  
Frederic Capuano ◽  
Marc J Claeys ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Quality Indicators ◽  
Position Paper ◽  
Care Association ◽  
Cardiovascular Care

scholarly journals Resources for Cardiovascular Healthcare associated with 30-day Mortality in Acute Myocardial Infarction with Cardiogenic Shock

2021 ◽  
Author(s):  
Masanobu Ishii ◽  
Kenichi Tsujita ◽  
Hiroshi Okamoto ◽  
Satoshi Koto ◽  
Takeshi Nishi ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Cardiogenic Shock ◽  
Coronary Intervention ◽  
Circulatory Support ◽  
Primary Pci ◽  
Healthcare Resources ◽  
Inverse Probability Weighted ◽  
Healthcare Associated ◽  
Cardiovascular Care

Abstract Background Although primary percutaneous coronary intervention (PCI) and mechanical circulatory support (MCS), such as extracorporeal membrane oxygenation (ECMO) or intra-aortic balloon pumping (IABP), have been widely used for acute myocardial infarction patients with cardiogenic shock (AMICS), their in-hospital mortality remains high. This study aimed to investigate the association of cardiovascular healthcare resources with 30-day mortality in AMICS. Methods This was an observational study using a Japanese nationwide administrative data (JROAD-DPC) of 260,543 AMI patients between April 2012 and March 2018. Of these, 45,836 AMICS patients were divided into three categories based on MCS use: with MCS (ECMO with/without IABP), IABP only, or without MCS. Certified hospital density and number of board-certified cardiologists were used as a metric of cardiovascular care supply. We estimated the association of MCS use, cardiovascular care supply, and 30-day mortality. Results The 30-day mortality was 71.2% for the MCS, 23.9% for IABP only, and 37.8% for the group without MCS. The propensity score-matched and inverse probability-weighted Cox frailty models showed that primary PCI was associated with a low risk for mortality. Higher hospital density and larger number of cardiologists in the responsible hospitals were associated with a lower risk for mortality. Conclusions Although the 30-day mortality remained extremely high in AMICS, indication of primary PCI and improvement in providing cardiovascular healthcare resources associated with the short-term prognosis of AMICS.

Sign in / Sign up

Export Citation Format

Share Document